# FDA Inspection 1187380 - Piedmont Reproductive Endocrinology Group, PA - November 01, 2022

Source: https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/b84b9103-6c4e-41f0-987f-e3380dbbda1b
Source feed: FDA_Inspections

> FDA Inspection 1187380 for Piedmont Reproductive Endocrinology Group, PA on November 01, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187380
- Company Name: Piedmont Reproductive Endocrinology Group, PA
- Inspection Date: 2022-11-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1298188 - 2026-01-09](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/a2c79c9a-3be3-4b19-99db-18b5584e0af2)
- [FDA Inspection 1187380 - 2022-11-01](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/11979c32-aa53-482d-af87-8289357b9d63)
- [FDA Inspection 1187380 - 2022-11-01](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/d8125cb6-54d1-40c4-be3a-fb5cf996725a)
- [FDA Inspection 1091218 - 2019-05-21](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/76f4cadf-8029-4429-a6d6-1b8a9e0d341e)
- [FDA Inspection 1091218 - 2019-05-21](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/728ce6d4-e345-44e6-81bf-2b802c921a42)

Company: https://www.keypedia.com/companies/piedmont-reproductive-endocrinology-group-pa/c852a71c-7b48-4de7-80e0-4999c4e09a02

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d